Common Drug Could Reduce COVID-19 Risk

Tejal Somvanshi

Bone-strengthening drugs linked to lower COVID-19 rates, as Harvard study of 450,000 patients shows reduced infection, diagnosis, and hospitalization.

Photo Source: Towfiqu barbhuiya (Pexels)

University of York scientists explain how bisphosphonates like alendronate and zoledronate may protect against COVID-19.

Photo Source: Chokniti Khongchum (Pexels)

Bisphosphonates bind to specific enzyme domains found in nidoviruses, including coronaviruses, which may inhibit viral replication.

Photo Source: Polina Tankilevitch (Pexels)

Researchers analyzed 7,817 existing drugs, narrowing down to 214 promising candidates in their search for COVID-19 treatments.

Photo Source: Ishaan Aggarwal (Pexels)

From screening 1,992 bisphosphonates, three drugs emerged as promising candidates: alendronate, zoledronate, and Japan's minodronate.

Photo Source: Mart Production(Pexels)

Current COVID-19 vaccines cannot prevent virus transmission, pushing scientists to find new treatments against mutating variants.

Photo Source: Frank Merino (Pexels)

Professor Seshadri Vasan's team created a specialized database in 2023 to help scientists narrow their search for COVID-19 fighting drugs.

Photo Source:  Alena Shekhovtcova (Pexels)

These approved osteoporosis medications represent a potential approach of using existing drugs for COVID-19 treatment.

Photo Source: Maksim Goncharenok (Pexels)

Scientists now plan clinical trials to explore these bone-strengthening drugs' potential against COVID-19 and other coronaviruses.

Photo Source: Miguel Á. Padriñán (Pexels)